Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101266602 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1172 (Electronic) Linking ISSN: 17501172 NLM ISO Abbreviation: Orphanet J Rare Dis Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: [London] : BioMed Central, 2006-
    • الموضوع:
    • نبذة مختصرة :
      Background: Limb-girdle muscular dystrophy (LGMD) is a rare neuromuscular disease including a growing and heterogeneous number of subtypes with variable phenotype. Their clinical and histopathological characteristics frequently overlap with other neuromuscular dystrophies. Our goal was to identify, by a non-invasive method, a molecular signature including biochemical and epigenetic parameters with potential value for patient prognosis and stratification.
      Results: Circulating miRNome was obtained by smallRNA-seq in plasma from LGMD patients (n = 6) and matched-controls (n = 6). Data, validated by qPCR in LGMD samples, were also examined in other common muscular dystrophies: Duchenne (DMD) (n = 5) and facioscapulohumeral muscular dystrophy (FSHD) (n = 4). Additionally, biochemical and clinical parameters were analyzed. miRNome analysis showed that thirteen differentially expressed miRs could separate LGMD vs control group by hierarchical clustering. Most of differentially expressed miRs in LGMD patients were up-regulated (miR-122-5p, miR-122b-3p, miR-6511a-3p, miR-192-5p, miR-574-3p, mir-885-3p, miR-29a-3p, miR-4646-3p, miR-203a-3p and miR-203b-5p) whilst only three of sequenced miRs were significantly down-regulated (miR-19b-3p, miR-7706, miR-323b-3p) when compared to matched controls. Bioinformatic analysis of target genes revealed cell cycle, muscle tissue development, regeneration and senescence as the most affected pathways. Four of these circulating miRs (miR-122-5p, miR-192-5p, miR-19b-3p and miR-323b-3p), together with the myomiR miR-206, were further analysed by qPCR in LGMD, DMD and FSHD. The receiver operating characteristic curves (ROC) revealed high area under the curve (AUC) values for selected miRs in all groups, indicating that these miRs have good sensitivity and specificity to distinguish LGMD, DMD and FSHD patients from healthy controls. miR-122-5p, miR-192-5p and miR-323-3p were differentially expressed compared to matched-controls in all groups but apparently, each type of muscular dystrophy showed a specific pattern of miR expression. Finally, a strong correlation between miRs and biochemical data was only found in LGMD patients: while miR-192-5p and miR-122-5p negatively correlated with CK, miR-192-5p positively correlated with vitamin D3 and ALP.
      Conclusions: Although limited by the small number of patients included in this study, we propose here a specific combination of circulating miR-122-5p/miR-192-5p/miR-323-3 and biochemical parameters as a potential molecular signature whose clinical value for LGMD patient prognosis and stratification should be further confirmed in a larger cohort of patients.
      (© 2022. The Author(s).)
    • References:
      J Cell Mol Med. 2014 Feb;18(2):208-17. (PMID: 24341522)
      Bioinformatics. 2014 Apr 1;30(7):923-30. (PMID: 24227677)
      Acta Myol. 2014 May;33(1):1-12. (PMID: 24843229)
      Nucleic Acids Res. 2013 May 1;41(10):e108. (PMID: 23558742)
      Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17016-21. (PMID: 17942673)
      Int J Mol Sci. 2019 Sep 19;20(18):. (PMID: 31546754)
      PLoS One. 2013 Dec 11;8(12):e83025. (PMID: 24349425)
      Mol Med Rep. 2014 May;9(5):1515-32. (PMID: 24626787)
      Nat Rev Neurol. 2016 Jan;12(1):6-8. (PMID: 26670295)
      PLoS Genet. 2011 Apr;7(4):e1002042. (PMID: 21533183)
      Skelet Muscle. 2020 Jul 29;10(1):22. (PMID: 32727611)
      Dis Model Mech. 2021 Aug 1;14(8):. (PMID: 34338285)
      Biochim Biophys Acta. 2015 Mar;1849(3):309-16. (PMID: 25598319)
      Bone. 2021 Apr;145:115787. (PMID: 33301964)
      Int J Mol Sci. 2017 Apr 15;18(4):. (PMID: 28420141)
      Biostatistics. 2008 Apr;9(2):321-32. (PMID: 17728317)
      Environ Health Prev Med. 2014 Nov;19(6):452-8. (PMID: 25150707)
      FEBS J. 2013 Sep;280(17):4294-314. (PMID: 23517348)
      OMICS. 2012 May;16(5):284-7. (PMID: 22455463)
      Nat Rev Genet. 2012 Apr 18;13(5):358-69. (PMID: 22510765)
      Genes (Basel). 2021 Jan 12;12(1):. (PMID: 33445560)
      Hum Mol Genet. 2008 Jun 15;17(12):1855-66. (PMID: 18334579)
      Am J Physiol Cell Physiol. 2021 Nov 1;321(5):C859-C875. (PMID: 34586896)
      FASEB J. 2011 Nov;25(11):3966-78. (PMID: 21840938)
      Neurology. 1983 Nov;33(11):1444-52. (PMID: 6685237)
      BMC Med Genet. 2020 Jan 9;21(1):11. (PMID: 31918667)
      Clin Genet. 2019 Oct;96(4):341-353. (PMID: 31268554)
      Genome Biol. 2010;11(3):R25. (PMID: 20196867)
      Ann Neurol. 2012 Mar;71(3):304-13. (PMID: 22451200)
      Bioinformatics. 2007 Nov 1;23(21):2881-7. (PMID: 17881408)
      Bioinformatics. 2016 Oct 1;32(19):3047-8. (PMID: 27312411)
      Bioinformatics. 2010 Jan 1;26(1):139-40. (PMID: 19910308)
      BMC Geriatr. 2021 Jul 20;21(1):433. (PMID: 34284726)
      Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20794-9. (PMID: 19933329)
      Sci Rep. 2016 Jun 21;6:28097. (PMID: 27323895)
      Cell Physiol Biochem. 2018;50(6):2176-2187. (PMID: 30415251)
      Sci Rep. 2017 Jul 12;7(1):5237. (PMID: 28701783)
      Cells. 2019 May 09;8(5):. (PMID: 31075875)
      Curr Opin Neurol. 2016 Oct;29(5):635-41. (PMID: 27490667)
      Neuromuscul Disord. 2022 Apr;32(4):332-346. (PMID: 35393236)
      Methods. 2001 Dec;25(4):402-8. (PMID: 11846609)
      Nat Cell Biol. 2009 Aug;11(8):973-9. (PMID: 19597488)
      Sci Rep. 2018 Feb 8;8(1):2646. (PMID: 29422531)
      JAMA Neurol. 2015 Dec;72(12):1424-32. (PMID: 26436962)
      FASEB J. 2020 Sep;34(9):12946-12962. (PMID: 32772437)
      Cell Oncol (Dordr). 2021 Feb;44(1):19-32. (PMID: 33188621)
      J Neuromuscul Dis. 2015 Sep 2;2(3):241-255. (PMID: 26870665)
      Front Neurol. 2022 Jul 06;13:921785. (PMID: 35873767)
      J Physiol. 2004 May 1;556(Pt 3):983-1000. (PMID: 14766942)
      Acta Myol. 2020 Dec 01;39(4):207-217. (PMID: 33458576)
      Neuromuscul Disord. 2018 Aug;28(8):690-701. (PMID: 30033203)
      Cancer Res. 2008 Dec 15;68(24):10105-12. (PMID: 19074876)
      Diagnostics (Basel). 2021 Sep 17;11(9):. (PMID: 34574045)
      J Neuromuscul Dis. 2015 Jul 22;2(s2):S7-S19. (PMID: 27858764)
    • Contributed Indexing:
      Keywords: Circulating miRs; Duchenne muscular dystrophy; Facioscapulohumeral muscular dystrophy; Limb girdle muscular dystrophies; Molecular signature
    • الرقم المعرف:
      0 (MicroRNAs)
    • الموضوع:
      Date Created: 20221227 Date Completed: 20221230 Latest Revision: 20230213
    • الموضوع:
      20231215
    • الرقم المعرف:
      PMC9793535
    • الرقم المعرف:
      10.1186/s13023-022-02603-3
    • الرقم المعرف:
      36575500